Gene · 2176
Papers2,586
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 2,586
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Beth Levine's Legacy: From the Discovery of BECN1 to Therapies. A Mentees' Perspective. | Front Cell Dev Biol | 2022 | 35832792 | PubTator, text mining | PubMed |
| Evaluation of Transcriptomic Responses in Livers of Mice Exposed to the Short-Chain PFAS Compound HFPO-DA. | Front Toxicol | 2022 | 35832492 | PubTator, text mining | PubMed |
| Niraparib plus nivolumab or niraparib plus ipilimumab in patients with platinum-sensitive advanced pancreatic cancer: a randomised, phase 1b/2 trial. | Lancet Oncol | 2022 | 35810751 | PubTator, text mining | PubMed |
| Can Cisplatin Therapy Be Improved? Pathways That Can Be Targeted. | Int J Mol Sci | 2022 | 35806243 | PubTator, text mining | PubMed |
| Whole Exome Sequencing Points towards a Multi-Gene Synergistic Action in the Pathogenesis of Congenital Combined Pituitary Hormone Deficiency. | Cells | 2022 | 35805171 | PubTator, text mining | PubMed |
| Germline Aberrations in Pancreatic Cancer: Implications for Clinical Care. | Cancers (Basel) | 2022 | 35805011 | PubTator, text mining | PubMed |
| Variants in PRKCE and KLC1, Potential Regulators of Type I Psoriasis. | Clin Cosmet Investig Dermatol | 2022 | 35800456 | PubTator, text mining | PubMed |
| Genome-wide detection of imprinted differentially methylated regions using nanopore sequencing. | Elife | 2022 | 35787786 | PubTator, text mining | PubMed |
| Homologous Recombination Deficiency in Ovarian, Breast, Colorectal, Pancreatic, Non-Small Cell Lung and Prostate Cancers, and the Mechanisms of Resistance to PARP Inhibitors. | Front Oncol | 2022 | 35785170 | PubTator, text mining | PubMed |
| Cas-Based Systems for RNA Editing in Gene Therapy of Monogenic Diseases: In Vitro and in Vivo Application and Translational Potential. | Front Cell Dev Biol | 2022 | 35784464 | PubTator, text mining | PubMed |
| RecQ Helicase Somatic Alterations in Cancer. | Front Mol Biosci | 2022 | 35782872 | PubTator, text mining | PubMed |
| Emerging strategies for the improvement of chemotherapy in bladder cancer: Current knowledge and future perspectives. | J Adv Res | 2022 | 35777908 | PubTator, text mining | PubMed |
| Role of Neuropilin-2-mediated signaling axis in cancer progression and therapy resistance. | Cancer Metastasis Rev | 2022 | 35776228 | PubTator, text mining | PubMed |
| Functional screening reveals HORMAD1-driven gene dependencies associated with translesion synthesis and replication stress tolerance. | Oncogene | 2022 | 35768547 | PubTator, text mining | PubMed |
| The impact of rare germline variants on human somatic mutation processes. | Nat Commun | 2022 | 35764656 | PubTator, text mining | PubMed |
| In-hospital mortality in SARS-CoV-2 stratified by sex diffrences: A retrospective cross-sectional cohort study. | Ann Med Surg (Lond) | 2022 | 35757308 | PubTator, text mining | PubMed |
2022 AHA/ACC Key Data Elements and Definitions for Cardiovascular and Noncardiovascular Complications of COVID-19: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards. | J Am Coll Cardiol | 2022 | 35753858 | PubTator, text mining | PubMed |
| Navigating the Evolving Landscape of Cardiovascular Training and Education. | Methodist Debakey Cardiovasc J | 2022 | 35734154 | PubTator, text mining | PubMed |
Spectrum of germline pathogenic variants using a targeted next generation sequencing panel and genotype-phenotype correlations in patients with suspected hereditary breast cancer at an academic medical centre in Pakistan. | Hered Cancer Clin Pract | 2022 | 35710434 | PubTator, text mining | PubMed |
| Hematopoietic stem cell regeneration through paracrine regulation of the Wnt5a/Prox1 signaling axis. | J Clin Invest | 2022 | 35703178 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2176/papers?page=25